1. Home
  2. TMDX vs CBT Comparison

TMDX vs CBT Comparison

Compare TMDX & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • CBT
  • Stock Information
  • Founded
  • TMDX 1998
  • CBT 2019
  • Country
  • TMDX United States
  • CBT United States
  • Employees
  • TMDX N/A
  • CBT N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CBT Major Chemicals
  • Sector
  • TMDX Health Care
  • CBT Industrials
  • Exchange
  • TMDX Nasdaq
  • CBT Nasdaq
  • Market Cap
  • TMDX 4.8B
  • CBT 4.0B
  • IPO Year
  • TMDX 2019
  • CBT N/A
  • Fundamental
  • Price
  • TMDX $117.54
  • CBT $71.74
  • Analyst Decision
  • TMDX Buy
  • CBT Hold
  • Analyst Count
  • TMDX 9
  • CBT 3
  • Target Price
  • TMDX $129.88
  • CBT $92.67
  • AVG Volume (30 Days)
  • TMDX 1.0M
  • CBT 308.9K
  • Earning Date
  • TMDX 07-30-2025
  • CBT 08-04-2025
  • Dividend Yield
  • TMDX N/A
  • CBT 2.48%
  • EPS Growth
  • TMDX N/A
  • CBT N/A
  • EPS
  • TMDX 1.41
  • CBT 7.72
  • Revenue
  • TMDX $488,227,000.00
  • CBT $3,908,000,000.00
  • Revenue This Year
  • TMDX $34.07
  • CBT N/A
  • Revenue Next Year
  • TMDX $20.76
  • CBT $3.32
  • P/E Ratio
  • TMDX $76.58
  • CBT $9.39
  • Revenue Growth
  • TMDX 64.43
  • CBT N/A
  • 52 Week Low
  • TMDX $55.00
  • CBT $71.64
  • 52 Week High
  • TMDX $177.37
  • CBT $117.46
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 52.35
  • CBT 36.15
  • Support Level
  • TMDX $104.71
  • CBT $74.78
  • Resistance Level
  • TMDX $110.00
  • CBT $78.61
  • Average True Range (ATR)
  • TMDX 5.69
  • CBT 1.57
  • MACD
  • TMDX 0.32
  • CBT -0.56
  • Stochastic Oscillator
  • TMDX 74.25
  • CBT 3.80

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: